Since the foundation of Eli Lilly 130, the company has been at the vanguard of many significant medical breakthroughs. Lilly was one of the first companies to initiate a bona fide pharmaceutical research program, hiring a pharmaceutical chemist as its first scientist. It was among the first few companies to develop a method to mass-produce penicillin, marking the beginning of a sustained effort to fight infectious diseases. In the year 2001, a major milestone was achieved by the organization. Lilly launched another first-in-class product, Xigris, for the treatment of severe sepsis in adult patients with a high risk of death. In 2001, they ... introduced several new compounds for regulatory review, like – atomoxetine, for the treatment of attention-deficit hyperactivity disorder in children, adolescents and adults; Cialis, for the treatment of erectile dysfunction; and duloxetine, for the treatment of major depressive disorder.